Assessment of damage in juvenile-onset systemic lupus erythematosus: A multicenter cohort study

Arthritis Care and Research

Volumn 49, Issue 4, 2003, Pages 501-507

  Ravelli, Angelo ^a   Duarte Salazar, Carolina ^b   Buratti, Silvia ^a,c   Reiff, Andreas ^c   Bernstein, Bram ^c   Maldonado Velazquez, Maria Rocio ^b   Beristain Manterola, Rosalia ^b   Maeno, Nobuaki ^d   Takei, Syuji ^d   Gerloni, Valeria ^e   Spencer, Charles H ^f   Pratsidou Gertsi, Polyxeni ^g   Ruperto, Nicolino ^a   Pistorio, Angela ^a   Martini, Alberto ^a  

^a G GASLINI INSTITUTE   (Italy)

^b Hospital Infantil   (Mexico)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d Japan Pediat Rheumatology Assoc   (Japan)

^e ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^f CHILDREN'S MEMORIAL HOSPITAL   (United States)

^g ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Organ damage; Systemic lupus erythematosus; Systemic Lupus Erythematosus Collaborating Clinics American College of Rheumatology Damage Index

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; EYE INJURY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL DISEASE; NEUROPSYCHIATRY; ONSET AGE; PREVALENCE; QUALITY OF LIFE; RATING SCALE; RISK FACTOR; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0042404130     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11205     Document Type: Article

References (41)

1. Zetterstrom R, Bergland G. Systemic lupus erythematosus in childhood: a clinical study. Paediatrica 1956;5:189-204.
2. Cook CD, Wedgewood RJT, Craig JM, Hartman JR, Janeway CA. Systemic lupus erythematosus: description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics 1960;26:570-85.
3. Meislin AG, Rothfield N. Systemic lupus erythematosus in childhood: analysis of 42 cases with comparative data in 200 adult cases followed concurrently. Pediatrics 1968;42:37-49.
4. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50:85-95.
5. Abeles M, Urman JD, Weinstein A, Lowenstein M, Rothfield NF. Systemic lupus erythematosus in the younger patient: survival studies. J Rheumatol 1980;7:515-22.
6. Caeiro F, Michielson FMC, Bernstein R, Hughes GRV, Ansell BM. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981;40:325-31.
7. Glidden RS, Mantzouranis EC, Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in 55 patients. Clin Immunol Immunopathol 1983;29:196-210.
8. Tucker LB, Menon S, Schaller JG, Isemberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
9. Platt JL, Burke BA, Fish AJ, Kim Y, Michael AF. Systemic lupus erythematosus in the first two decades of life. Am J Kidney Dis 1982;2 Suppl 1:212-22.
10. Gladman DD, Ginzler E, Goldsmith CH, Fortin P, Liang M, Urowitz MB, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Bombardier C, Gladman DD, Urowitz MB, Charron D, Chang CH. The development and validation of the SLE disease activity index (SLEDAI). Arthritis Rheum 1992;35:630-40.
13. Ruperto N, Ravelli A, Pistorio A, Malattia C, Viola S, Cavuto S, et al. The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. In press. Clin Exp Rheumatol 2001;19 Suppl 23:S91-5.
14. Ruperto N, Ravelli A, Pistorio A, Malattia C, Viola S, Cavuto S, et al. The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. In press. Clin Exp Rheumatol 2001;19 Suppl 23:S91-5.
15. Pratsidou-Gertsi P, Vougiouka O, Tsitsami E, Ruperto N, Siamopoulou-Mavridou A, Dracou C, et al. The Greek version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19 Suppl 23:S76-80.
16. Landgraf JM, Abetz L, Ware JEJ. The CHQ user's manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.
17. Duarte C, Ruperto N, Goycochea MV, Maldonado R, Beristain R, De Inocencio J, et al. The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19 Suppl 23:S106-10.
18. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 1989.
19. Walravens PA, Chase PH. The prognosis of childhood systemic lupus erythematosus. Am J Dis Child 1976;130:929-33.
20. Fish AJ, Blau EB, Westberg NG, Burke BA, Vernier RL, Michael AF. Systemic lupus erythematosus within the first two decades of life. Am J Med 1977;62:99-117.
21. King KK, Kornreich HK, Bernstein BH, Singsen BH, Hanson V. The clinical spectrum of systemic lupus erythematosus in childhood. Arthtritis Rheum 1977;20:287-94.
22. Cassidy JT, Sullivan DB, Petty RE, Ragsdale C. Lupus nephritis and encephalopathy. Prognosis in 58 children. Arthritis Rheum 1977;20:315-22.
23. Lehmann TJA. Long-term outcome of systemic lupus erythematosus in childhood. What is the prognosis? Rheum Dis Clin Noth Am 1991;17:921-30.
24. Shergy WJ, Kredich DW, Pisetsky DS. Patterns of autoantibody expression in pediatric and adult systemic lupus erythematosus. J Rheum 1993;16:1329-34.
25. Ward MM, Dawson DV, Kredich DW, Pisetsky DS. Expression of IgM and IgG autoantibodies in pediatric and adult onset systemic lupus erythematosus. Clin Immunol Immonopathol 1990;55:273-84.
26. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic, and immunogenetic studies in childhood onset systemic lupus erythematosus. Arthritis Rheum 1993;36:348-54.
27. Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jimenéz S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998;57:456-9.
28. Carreno L, Lopez-Longo FJ, Monteagudo I, Rodriguez-Mahou M, Bascones M, Gonzalez CM, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999;8:287-92.
29. Lacks S, White P. Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 1990;17:941-5.
30. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
31. Stoll T, Seifert B, Isenberg DA. SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996;35:248-54.
32. Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 1997;24:309-13.
33. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
34. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez MdL, Jimenez-Balderas FJ, Aceves-Avila J, et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998;7:119-23.
35. Nossent JC. SLICC/ACR damage index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J Rheumatol 1998;25:654-9.
36. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999;38:1130-7.
37. Rivest C, Lew RA, Welsing PMJ, Sangha O, Wright EA, Roberts WN, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000;27:680-4.
38. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000;43:1801-8.
39. Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood systemic lupus erythemnatosus. Arthritis Rheum 1981;24:1389-94.
40. Steinlin MI, Blaser SI, Gilday DL, Eddy AA, Logan WJ, Laxer RM, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995;13:191-7.
41. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436-44.